• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Health Sci Rep . Follow-up the severity of abnormalities diagnosed in chest CT imaging of COVID-19 patients: A cross-sectional study

tetano

Editor, Senior Moderator
Health Sci Rep


. 2022 Sep 12;5(5):e818.
doi: 10.1002/hsr2.818. eCollection 2022 Sep.
Follow-up the severity of abnormalities diagnosed in chest CT imaging of COVID-19 patients: A cross-sectional study


Fatemeh Honarmandpour[SUP] 1 [/SUP], Azam Jahangirimehr[SUP] 2 [/SUP], Marziyeh Tahmasbi[SUP] 3 [/SUP], Azam Khalighi[SUP] 4 [/SUP], Azam Honarmandpour[SUP] 5 [/SUP]



Affiliations

Abstract

Background and aims: This study aimed to evaluate the severity of diagnosed lung abnormalities of coronavirus disease 2019 (COVID-19) patients based on the pre-and postrecovery follow-up chest computed tomography (CT) scan findings done at regular intervals.
Methods: This cross-sectional study was performed in three phases. The severity of lung abnormalities was recorded and compared based on the initial and follow-up chest CT findings carried out pre-and at regular intervals (3 and 6 months) of postrecovery of COVID-19 patients. Statistical data analysis was conducted using SPSS-Version 26. Pearson Chi-square test was used to analyze the results. p-value < 0.05 was considered statistically significant.
Results: Regarding the initial chest CT findings, although ground-glass opacity (GGO) was observed as the most common lung lesion, almost all the evaluated COVID-19 patients had multiple lung lesions and involvements, especially with more involvement of the lower lobes. concerning the frequency of lung lesions and involvements in all phases of the study, almost no statistically significant differences were observed between male and female COVID-19 patients and different age groups. However, older age groups had relatively more lung abnormalities due to Covid-19 based on initial CT images which take more time to be eliminated. Lung abnormalities of Covid-19 patients decreased significantly during the follow ups based on chest CT findings at different study phases.
Conclusion: According to evaluated pre- and post-recovery chest CT scans, the frequency of lung lesions and lung involvement distribution decreased significantly in COVID-19 patients, 3 and 6 months after recovery, and most of the recovered patients had no lung lesions or involvement anymore.

Keywords: COVID‐19; CT manifestations; follow‐up study; lung involvement; lung lesion.
 
Back
Top Bottom